Stay updated on MBG453 Combo with Azacitidine & Venetoclax Clinical Trial

Sign up to get notified when there's something new on the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The history page adds a new entry 'Revision: v3.3.3' and removes the footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.1%
    Check dated 2025-12-23T21:21:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision from v3.2.0 to v3.3.2 is reflected on the page; no study data or page content is affected.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:13.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Novartis decided to early terminate the sabatolimab clinical development program, including the CMBG453C12201 trial, following negative results from two other trials. The history also removes a government-funding notice and records that the study was terminated due to negative results across the program.
    Difference
    0.8%
    Check dated 2025-11-18T07:13:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The new screenshot shows a refreshed layout of the Record History page with the same study information and version list as the old screenshot, indicating no substantive edits to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:23:17.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page now adds a complete study protocol/results framework and status metadata, significantly expanding core content; nothing was removed.
    Difference
    3%
    Check dated 2025-10-20T14:17:44.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Upgrade notice issued: new funding/status notice and v3.2.0 release replaces v3.1.0; page now publicly states current version and operating status details.
    Difference
    9%
    Check dated 2025-10-13T11:49:12.000Z thumbnail image

Stay in the know with updates to MBG453 Combo with Azacitidine & Venetoclax Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page.